Episode 373: Biomarker Testing in Prostate Cancer
Description
"Next-generation sequencing, or NGS, can be used to help us determine if the patient has specific biomarkers we can identify and use to target for treatment. Certain findings can tell us if a particular treatment might work for that patient, and we can see if there are any genetic variants we might have a biomarker targeted agent to use to treat them with," ONS member Jackie Peterson, MSN, RN, OCN®, NE-BC, MBA, ambulatory nurse manager at the University of Chicago Medical Center in Illinois, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about prostate cancer and biomarker testing.
This podcast is sponsored by AstraZeneca and is not eligible for NCPD contact hours. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Episode Notes
- This episode is not eligible for NCPD.
- ONS Podcast™ episodes:
- ONS Voice articles:
- An Oncology Nurse's Guide to Cascade Testing
- Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Disorders
- Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
- Germline and Somatic Variants: What Is the Difference?
- Help Patients Understand Genomic Variants of Unknown Significance
- Prostate Cancer Clinical Trials Don't Reflect Racial Diversity—And It's Getting Worse Over Time
- Prostate Cancer Disparities Disappear With Equal Access to Care
- Prostate Cancer Prevention, Screening, Treatment, and Survivorship Recommendations
- The Case of the Genomics-Guided Care for Prostate Cancer
- ONS book: Understanding Genomic and Hereditary Cancer Risk: A Handbook for Oncology Nurses
- ONS course: Genomic Foundations for Precision Oncology
- Clinical Journal of Oncology Nursing articles:
- Oncology Nursing Forum article: Identification of Symptom Profiles in Prostate Cancer Survivors
- Other ONS Resources:
- Biomarker Database (refine by prostate cancer or specific biomarkers)
- Clinical tool/case study: Biomarker Testing in Prostate Cancer: The Role of the Oncology Nurse
- Genomics and Precision Oncology Learning Library
- Huddle Card: Genomic Biomarkers
- Infographic: Talking to Your Patient About a Germline Variant of Uncertain Significance (VUS)
- American Cancer Society
United States
